What is the primary purpose of this 8-K filing for HCA Healthcare?

This 8-K filing announces the entry into a material definitive agreement, specifically the completion of a $4.5 billion public offering of senior unsecured notes by HCA Inc., guaranteed by the parent company HCA Healthcare, Inc. It provides details on the terms, maturities, interest rates, and covenants associated with these new debt instruments.

What are the key terms of the new senior notes issued?

The offering includes $1.0 billion of 5.450% Senior Notes due 2031, $1.3 billion of 5.600% Senior Notes due 2034, $1.5 billion of 6.000% Senior Notes due 2054, and $0.7 billion of 6.100% Senior Notes due 2064. Interest is payable semi-annually.

How do these new notes rank in HCA Healthcare's capital structure?

The notes are the senior unsecured obligations of HCA Inc. They rank equally with existing and future senior indebtedness of HCA Inc. However, they are effectively subordinated to any secured indebtedness of HCA Inc. to the extent of the collateral securing it, and structurally subordinated to all existing and future indebtedness and liabilities of HCA's subsidiaries.

What protections do noteholders have in case of significant corporate changes?

The indenture includes provisions for optional redemption by the issuer. More importantly for investors, upon the occurrence of both a qualifying ratings downgrade and certain changes of control, noteholders have the right to require HCA Inc. to repurchase their notes at 101% of the principal amount, plus accrued interest.

HCA 8-K: Material Agreements & Financial Events

Summary

HCA Healthcare, Inc. (HCA) has filed an 8-K report detailing a significant financing transaction. On February 23, 2024, the company, through its subsidiary HCA Inc., successfully completed the public offering of $4.5 billion in aggregate principal amount of senior unsecured notes. These notes are structured across various maturity dates and interest rates, including $1.0 billion of 5.450% notes due 2031, $1.3 billion of 5.600% notes due 2034, $1.5 billion of 6.000% notes due 2054, and $0.7 billion of 6.100% notes due 2064. The parent company, HCA Healthcare, Inc., fully and unconditionally guarantees these notes. This substantial debt issuance, registered under a Form S-3 shelf registration statement, provides HCA with significant capital. The proceeds are intended to fund general corporate purposes, which may include capital expenditures, debt repayment, or acquisitions, although specific use of proceeds is not detailed in this filing. The indenture governing these notes includes standard covenants related to liens, sale and lease-back transactions, and asset disposals, as well as provisions for optional redemption and a change of control repurchase right for noteholders under specific conditions. Investors should note that while these notes are senior unsecured obligations of the issuer, they are effectively subordinated to secured debt and structurally subordinated to the debt and liabilities of HCA's subsidiaries.

Key Highlights

1HCA Healthcare completed a $4.5 billion public offering of senior unsecured notes on February 23, 2024.
2The notes are issued by subsidiary HCA Inc. and guaranteed by the parent company, HCA Healthcare, Inc.
3The offering is comprised of four tranches with varying maturities and coupon rates: 5.450% (2031), 5.600% (2034), 6.000% (2054), and 6.100% (2064).
4The notes are governed by a base indenture and specific supplemental indentures for each series.
5Key covenants include restrictions on liens, sale and lease-back transactions, and asset dispositions.
6Notes holders have a right to require repurchase upon a change of control event combined with a ratings downgrade.
7The filing incorporates by reference the material definitive agreement details into Item 2.03 regarding creation of a financial obligation.

HCA Healthcare, Inc. 8-K Report, Material Agreement (Feb 23, 2024)

Summary

Key Highlights

Frequently Asked Questions